[HTML][HTML] Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase
Journal of Clinical Oncology, 2010•ncbi.nlm.nih.gov
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early
Chronic Phase - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2815701 Other Formats PubReader PDF (214K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Chronic Phase - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2815701 Other Formats PubReader PDF (214K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
Purpose
Although most patients with chronic myeloid leukemia (CML) in chronic phase respond well to front-line therapy with imatinib, some patients do not achieve the desirable end point, and others may eventually lose response or are intolerant.
ncbi.nlm.nih.gov